Ambalal Sarabhai Enterprises Balance Sheet Annual

Trade

BSE: 500009 | NSE: - | ISIN: INE432A01017 | Sector: Major Drugs

56.70 +1.57 (2.85%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	32.90	4.39	4.17	3.15
Short Term Investments	4.95	23.18	13.36	13.12
Cashand Short Term Investments	37.86	33.38	25.54	27.93
Accounts Receivable- Trade Net	26.26	27.86	28.43	39.05
Total Receivables Net	44.65	59.02	73.26	71.16
Total Inventory	16.18	19.07	18.22	17.64
Other Current Assets Total	19.86	4.71	2.71	3.45
Total Current Assets	118.54	116.64	120.19	120.59
Property/ Plant/ Equipment Total- Net	63.04	64.28	45.41	33.06
Goodwill Net	24.50	24.52	24.52	24.53
Intangibles Net	0.02	0.02	0.03	0.04
Long Term Investments	44.05	35.08	32.62	27.30
Other Long Term Assets Total	0.07	3.47	4.58	3.06
Total Assets	250.23	245.74	230.50	210.05
Accounts Payable	36.70	36.98	47.30	50.40
Notes Payable/ Short Term Debt	36.03	22.09	22.90	20.75
Current Portof LT Debt/ Capital Leases	0.31	0.87	0.49	1.81
Other Currentliabilities Total	29.28	22.97	20.07	34.73
Total Current Liabilities	102.32	95.17	105.47	128.54
Long Term Debt	9.06	18.05	2.73	5.17
Capital Lease Obligations	0.71	0.91	0.63	0.20
Total Long Term Debt	9.77	18.96	3.36	5.37
Total Debt	46.11	41.93	26.75	27.94
Deferred Income Tax	0.32	0.03	-	-
Minority Interest	0.01	0.01	-0.01	-0.01
Other Liabilities Total	0.68	0.64	1.82	2.25
Total Liabilities	113.10	114.82	110.63	136.15
Common Stock Total	76.63	76.63	76.63	76.63
Retained Earnings( Accumulated Deficit)	60.50	44.25	33.20	-13.58
Total Equity	137.13	130.92	119.87	73.90
Total Liabilities Shareholders' Equity	250.23	245.74	230.50	210.05
Total Common Shares Outstanding	7.66	7.66	7.66	7.66
Tangible Book Valueper Share Common Eq	14.69	13.88	12.44	6.44
Cash	-	5.81	8.00	11.66
Prepaid Expenses	-	0.47	0.46	0.41
Property/ Plant/ Equipment Total- Gross	-	80.26	58.87	43.97
Accumulated Depreciation Total	-	-15.98	-13.46	-10.91
Note Receivable- Long Term	-	1.72	3.15	1.47
Accrued Expenses	-	12.25	14.70	20.85
Additional Paid- In Capital	-	10.61	10.61	10.61
Other Equity Total	-	-0.57	-0.57	0.24